Sotorasib Plus Panitumumab Compared to Standard Therapy in Chemorefractory Metastatic CRC

▸ TREATMENT

A matching-adjusted indirect comparison evaluated sotorasib plus panitumumab versus trifluridine/tipiracil plus bevacizumab in chemorefractory metastatic colorectal cancer. (Clinical Colorectal Cancer)